Challenges for clinical practice and research in family medicine in reducing the risk of chronic diseases. Notes on the EGPRN Spring Conference 2017 in Riga

publishersversionPeer reviewe

Real World: Empowering Representations of Women through Film

This article makes an argument for the added value of the use of documentary film in development research communication. It draws broadly on the specific experience of the Real World film scheme developed by the Pathways of Women's Empowerment Research Programme Consortium and Creative England, to create empowering representations of women. It argues that both researchers and film?makers have much to gain by collaborating on the political project of co?crafting a visual argument, to create a nuanced and emotive end product

The 2020 Covid-19 pandemic and global value chains

This paper considers the impact of the Covid-19 pandemic on firm strategies and, in particular, the configuration of firms’ global value chains (GVCs) once the pandemic has been brought under control. The merits of alternative location strategies (international diversification vs reshoring) are compared, as are the merits of different governance arrangements (internalization vs externalization) for GVC activities. The possibility of fire-sale foreign direct investment is raised, and the wider geopolitical context is emphasized. The widespread human tragedy is noted, as is the dilemma facing national governments around the world in balancing lives and livelihoods

New psychoactive substances (NPS) on cryptomarket fora: An exploratory study of characteristics of forum activity between NPS buyers and vendors

Background The continual diversification of new psychoactive substances (NPS) circumventing legislation creates a public health and law enforcement challenge, and one particularly challenged by availability on Hidden Web cryptomarkets. Methods This is the first study of its kind which aimed to explore and characterise cryptomarket forum members’ views and perspectives on NPS vendors and products within the context of Hidden Web community dynamics. An internal site search was conducted on two cryptomarkets popular with NPS vendors and hosting fora; Alphabay and Valhalla, using the search terms of 40 popular NPS in the seven categories of stimulant/cathinone; GABA activating; hallucinogen, dissociative, cannabinoid, opioid and other/unspecified/uncategorised NPS. 852 identified threads relating to the discussion of these NPS were generated. Following exclusion of duplicates, 138 threads remained. The Empirical Phenomenological Psychological method of data analysis was applied. Four themes and 32 categories emerged. Results 120 vendors selling NPS were visible on Alphabay, and 21 on Valhalla. Themes were ‘NPS Cryptomarkets and Crypto-community interest in NPS’ ‘Motives for NPS use’ ‘Indigenous Crypto Community Harm Reduction’ and ‘Cryptomarket Characteristics underpinning NPS trafficking’, with two higher levels of abstraction centring on ‘NPS vendor reputation’ and ‘NPS transactioning for personal use’. NPS cryptomarket characteristics centred on generation of trust, honesty and excellent service. Users appeared well informed, with harm reduction and vendor information exchange central to NPS market dynamics. GABA activating substances appeared most popular in terms of buyer interest on cryptomarkets. Interest in sourcing ‘old favorite’ stimulant and dissociative NPS was evident, alongside the sequential and concurrent poly use of NPS, and use of NPS with illicit drugs such as MDMA. Conclusion Continued monitoring of new trends in NPS within Surface Web and cryptomarkets are warranted. A particular focus on the rising market in prescribed benzodiazepine and Z-hypnotic drugs should be included. © 2016 Elsevier B.V

Linking Management Effectiveness Indicators to Observed Effects of Protected Areas on Fire Occurrence in the Amazon Rainforest

Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/96420/1/cobi1930.pd

Brine utilisation for cooling and salt production in wind-driven seawater greenhouses:Design and modelling

Brine disposal is a major challenge facing the desalination industry. Discharged brines pollute the oceans and aquifers. Here is it proposed to reduce the volume of brines by means of evaporative coolers in seawater greenhouses, thus enabling the cultivation of high-value crops and production of sea salt. Unlike in typical greenhouses, only natural wind is used for ventilation, without electric fans. We present a model to predict the water evaporation, salt production, internal temperature and humidity according to ambient conditions. Predictions are presented for three case studies: (a) the Horn of Africa (Berbera) where a seawater desalination plant will be coupled to salt production; (b) Iran (Ahwaz) for management of hypersaline water from the Gotvand dam; (c) Gujarat (Ahmedabad) where natural seawater is fed to the cooling process, enhancing salt production in solar salt works. Water evaporation per face area of evaporator pad is predicted in the range 33 to 83 m3/m2·yr, and salt production up to 5.8 tonnes/m2·yr. Temperature is lowest close to the evaporator pad, increasing downwind, such that the cooling effect mostly dissipates within 15 m of the cooling pad. Depending on location, peak temperatures reduce by 8–16 °C at the hottest time of year

Effect of the Pre-erythrocytic Candidate Malaria Vaccine RTS,S/AS01E on Blood Stage Immunity in Young Children

(See the article by Greenhouse et al, on pages 19-26.

HCV-related burden of disease in Europe: a systematic assessment of incidence, prevalence, morbidity, and mortality

Background Hepatitis C virus (HCV) is a leading cause of chronic liver disease, end-stage cirrhosis, and liver cancer, but little is known about the burden of disease caused by the virus. We summarised burden of disease data presently available for Europe, compared the data to current expert estimates, and identified areas in which better data are needed. Methods Literature and international health databases were systematically searched for HCV-specific burden of disease data, including incidence, prevalence, mortality, disability-adjusted life-years (DALYs), and liver transplantation. Data were collected for the WHO European region with emphasis on 22 countries. If HCV-specific data were unavailable, these were calculated via HCV-attributable fractions. Results HCV-specific burden of disease data for Europe are scarce. Incidence data provided by national surveillance are not fully comparable and need to be standardised. HCV prevalence data are often inconclusive. According to available data, an estimated 7.3–8.8 million people (1.1–1.3%) are infected in our 22 focus countries. HCV-specific mortality, DALY, and transplantation data are unavailable. Estimations via HCV-attributable fractions indicate that HCV caused more than 86000 deaths and 1.2 million DALYs in the WHO European region in 2002. Most of the DALYs (95%) were accumulated by patients in preventable disease stages. About one-quarter of the liver transplants performed in 25 European countries in 2004 were attributable to HCV. Conclusion Our results indicate that hepatitis C is a major health problem and highlight the importance of timely antiviral treatment. However, data on the burden of disease of hepatitis C in Europe are scarce, outdated or inconclusive, which indicates that hepatitis C is still a neglected disease in many countries. What is needed are public awareness, co-ordinated action plans, and better data. European physicians should be aware that many infections are still undetected, provide timely testing and antiviral treatment, and avoid iatrogenic transmission